Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 19:2021:7427500.
doi: 10.1155/2021/7427500. eCollection 2021.

Epidemiological Features and Predictors of Mortality in Patients with COVID-19 with and without Underlying Hypertension

Leila Moftakhar  1   2 , Elahe Piraee  2 , Mohammad Mohammadi Abnavi  2 , Parisa Moftakhar  3 , Habibollah Azarbakhsh  2 , Aliasghar Valipour  4
Affiliations

Epidemiological Features and Predictors of Mortality in Patients with COVID-19 with and without Underlying Hypertension

Leila Moftakhar et al. Int J Hypertens. .

Abstract

Backgrounds: Individuals with hypertension are at higher risk of COVID-19 infection and related mortality. This study was carried out to assess the epidemiological features and predictors of mortality in patients with COVID-19 with hypertension.

Methods: In this retrospective study, the epidemiological characteristics of two groups of patients with COVID-19 with hypertension (1927) and without hypertension (39030) were compared. Chi-square test was applied to evaluate the differences between qualitative variables in two study groups. Logistic regression was also used to determine predictors of mortality in patients with COVID-19 and in patients with COVID-19 with hypertension.

Results: The prevalence of hypertension in patients with COVID-19 was 4.7%, and 24.37% of COVID-19 related deaths occurred in these individuals. The average age of hypertension and nonhypertension patients was 61 and 37 years, respectively. Fever, cough, headache, anorexia, fatigue, and comorbid diseases, such as cardiovascular disease, chronic lung and kidney disease, diabetes, immunodeficiency disease, and thyroid disease, were significantly more frequent in people with hypertension than those without hypertension. The chances of mortality in patient with COVID-19 were 1.8 times higher in individuals with dyspnea, 1.25 in individuals with fever, 1.33 in individuals with cough, 3.6 in patients with hypertension, 2.21 in diabetics, and 2.2 in individuals with cardiovascular disease. Also, individuals with COVID-19 with hypertension that had dyspnea, immunodeficiency, and cardiovascular disease were at higher risk of mortality.

Conclusion: Hypertension is a serious threat to patients with COVID-19. Therefore, in order to control these patients more precisely and reduce mortality in them, it is extremely important to develop prevention and treatment strategies.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

References

    1. Moftakhar L., Moftakhar P., Piraee E., Ghaem H, Valipour A, Azarbakhsh H. Epidemiological characteristics and outcomes of COVID-19 in diabetic versus non-diabetic patients. International Journal of Diabetes in Developing Countries . 2021;41(3):1–6. doi: 10.1007/s13410-021-00930-y. - DOI - PMC - PubMed
    1. Moftakhar L., Seif M. The exponentially increasing rate of patients infected with COVID-19 in Iran. Archives of Iranian Medicine . 2020;23(4):235–238. doi: 10.34172/aim.2020.03. - DOI - PubMed
    1. Yi H. 2019 novel coronavirus is undergoing active recombination. Clinical Infectious Diseases . 2020;71(15):884–887. doi: 10.1093/cid/ciaa219. - DOI - PMC - PubMed
    1. https://www.worldometers.info/coronavirus/
    1. Singh A. K., Gupta R., Misra A. Comorbidities in COVID-19: outcomes in hypertensive cohort and controversies with renin angiotensin system blockers. Diabetes & Metabolic Syndrome: Clinical Research Reviews . 2020;14(4):283–287. doi: 10.1016/j.dsx.2020.03.016. - DOI - PMC - PubMed

LinkOut - more resources